Posters modérés - PK et pharmacogénétique de Ac Monoclonaux et Anticancéreux
mercredi 16 juin 2021
Posters
•
S19
•
12h20
>
00h00
•
Posters modérés - PK et pharmacogénétique de Ac Monoclonaux et Anticancéreux
•
Posters
•
250
•
PM-069 - Population pharmacokinetics of adalimumab in patients with inflammatory diseases: a new model to predict immunization to subcutaneous anti-TNF drugs
>
A.
Antoine
Petitcollin
•
319
•
PM-070 - Fate of trastuzumab after intrathecal administrations: a possible influence of antigen mass
>
O.
Olivier
LE TILLY
•
388
•
PM-071 - Genetic variations of CYP450 and ABC transporters associated with trabectedin severe hepatotoxicity in patients with advanced soft-tissue sarcoma: a pharmacogenetic study
>
M.
Maud
Maillard
•
395
•
PM-072 - Cytarabine, Idarubicin and Daunorubicin and their active metabolites pharmacokinetic evaluations in young untreated adult patients with acute myeloid leukemia (AML) included in the ALFA/FILO BIG-1 clinical trial: the LAM-PK study
>
C.
Chadi
Abbara
•
407
•
PM-073 - Revisiting target-mediated elimination of therapeutic antibodies: the irreversible binding approximation
>
D.
David
Ternant
|